Preliminary study on the absorption profile after rectal and oral administration of methadone in human volunteers
- PMID: 6549062
- DOI: 10.1007/BF01954551
Preliminary study on the absorption profile after rectal and oral administration of methadone in human volunteers
Abstract
Methadone is a potent, long acting narcotic analgesic which can be orally administered due to its almost complete bioavailability. There is a growing interest in the rectal route of administration in the case of acute post-operative or chronic malignant pain. Since virtually no data were available on the rectal absorption profile of methadone in man, plasma concentrations of methadone were determined by means of HPLC analysis after a single dose of 10 mg methadone HCl in a cross-over pilot study in five volunteers. The rectal dosage forms included aqueous solutions and fatty suppositories. A comparison was made with an orally administered solution. Compared with oral dosing, the extent of rectal absorption from an aqueous solution was almost 80% up to 8 h after dosing. Although the mean peak concentration and the AUC0-8h was significantly lower (p less than 0.01), no marked difference in tmax was observed: 2.8 and 3.1 h respectively. Rectal absorption conditions of methadone from fatty suppositories (3 ml) were found to be less favourable. The peak plasma concentration was only reached 3-4 h after administration, whereas the relative bioavailability up to 8 h after dosing ranged from 35-58%. This rate-limiting absorption pattern may be due to the critical solubility properties of methadone HCl at physiological pH.
Similar articles
-
Bioavailabilities of rectal and oral methadone in healthy subjects.Br J Clin Pharmacol. 2004 Aug;58(2):156-62. doi: 10.1111/j.1365-2125.2004.02116.x. Br J Clin Pharmacol. 2004. PMID: 15255797 Free PMC article. Clinical Trial.
-
Rectal versus oral absorption of codeine phosphate in man.Biopharm Drug Dispos. 1983 Apr-Jun;4(2):195-9. doi: 10.1002/bdd.2510040212. Biopharm Drug Dispos. 1983. PMID: 6683976 Clinical Trial.
-
Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.Arzneimittelforschung. 1998 Sep;48(9):889-99. Arzneimittelforschung. 1998. PMID: 9793614 Clinical Trial.
-
High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.Clin Pharmacokinet. 1986 Mar-Apr;11(2):87-106. doi: 10.2165/00003088-198611020-00001. Clin Pharmacokinet. 1986. PMID: 3514045 Review.
-
Rectal drug administration: clinical pharmacokinetic considerations.Clin Pharmacokinet. 1982 Jul-Aug;7(4):285-311. doi: 10.2165/00003088-198207040-00002. Clin Pharmacokinet. 1982. PMID: 6126289 Review.
Cited by
-
Pharmacokinetics of rectal drug administration, Part II. Clinical applications of peripherally acting drugs, and conclusions.Clin Pharmacokinet. 1991 Aug;21(2):110-28. doi: 10.2165/00003088-199121020-00003. Clin Pharmacokinet. 1991. PMID: 1884566 Review.
-
Bioavailabilities of rectal and oral methadone in healthy subjects.Br J Clin Pharmacol. 2004 Aug;58(2):156-62. doi: 10.1111/j.1365-2125.2004.02116.x. Br J Clin Pharmacol. 2004. PMID: 15255797 Free PMC article. Clinical Trial.
-
Drastic improvement in the rectal absorption profile of morphine in man.Eur J Clin Pharmacol. 1985;29(1):119-21. doi: 10.1007/BF00547380. Eur J Clin Pharmacol. 1985. PMID: 4054201
-
Advanced and controlled drug delivery systems in clinical disease management.Pharm World Sci. 1996 Oct;18(5):153-62. doi: 10.1007/BF00820726. Pharm World Sci. 1996. PMID: 8933575 Review.